Accelerating Medicine Partnership (AMP)
In 2014, the Foundation for the National Institutes of Health announced the creation of the Accelerating Medicines Partnership (AMP). This is a five-year initiative that will help develop new treatments faster for several complex diseases. Lupus is one of the four disease projects under this effort.
This $230 million project brings together government, academia, industry, and nonprofit health organizations to support research to understand the underlying causes of specific diseases and identify and confirm the right biologic targets for drug development.
AMP’s initiative for lupus and rheumatoid arthritis includes six biopharmaceutical companies and five nonprofit organizations, including the Lupus Foundation of America. This year, the initiative shared the first set of searchable data-sets, which is open for researchers to use to support AMP’s goal of finding new treatments faster.